IBS-C stands for irritable bowel syndrome with constipation. It’s a subtype of IBS where recurring abdominal pain comes paired with hard, infrequent stools. What separates IBS-C from ordinary constipation is that pain is a central feature, not just a side effect of straining.
How IBS-C Differs From Regular Constipation
Many people experience constipation from time to time, but IBS-C is a specific diagnosis with defined criteria. The Rome IV guidelines, the international standard for diagnosing functional gut disorders, require recurrent abdominal pain at least one day per week for three months, with symptoms first appearing at least six months before diagnosis. That pain must also be connected to bowel movements: it changes when you go, gets better or worse with a bowel movement, or shifts alongside changes in stool frequency or appearance.
Chronic idiopathic constipation (sometimes called functional constipation) can look similar on the surface. You might strain, go fewer than three times a week, or feel like you haven’t fully emptied. But the Rome IV criteria treat IBS-C and chronic constipation as two distinct conditions, with abdominal pain as the dividing line. If constipation is your main issue and pain isn’t prominent, the diagnosis is more likely functional constipation. If pain is a defining part of your experience, IBS-C is the more accurate label, and the treatment approach can differ.
What IBS-C Feels Like Day to Day
The constipation in IBS-C is defined by stool consistency, not just frequency. Clinicians use the Bristol Stool Scale, a seven-type visual chart, to classify stools. Types 1 and 2 characterize the constipation end: Type 1 is separate hard lumps like pebbles, and Type 2 is lumpy and sausage-shaped but still hard and difficult to pass. In IBS-C, more than 25% of your bowel movements fall into these categories, while loose stools are rare.
Beyond the bathroom, the abdominal pain can range from a dull, persistent ache to sharp cramping. Bloating is extremely common and often the symptom people find most disruptive. Many people describe feeling “backed up” with visible abdominal distension that worsens through the day. The symptoms tend to come in waves, with flare-ups lasting days or weeks followed by calmer periods.
What Causes It
IBS-C doesn’t have a single cause. It results from several overlapping problems in how the gut and brain communicate. One of the most important is visceral hypersensitivity, a state where your intestinal nerves overreact to normal stimuli. Things that a healthy gut wouldn’t register, like gas passing through or stool sitting in the colon, get amplified into pain signals that travel through the spinal cord to the brain. This is why people with IBS-C can experience significant pain even when imaging and blood work look completely normal.
The motility of the colon also plays a role. In IBS-C, the muscular contractions that push stool forward tend to be slower or less coordinated, giving the colon more time to absorb water and leaving stool harder and drier. Serotonin, a chemical messenger that regulates gut contractions (about 95% of the body’s serotonin is actually in the gut), is often disrupted in IBS.
The gut microbiome adds another layer. People with IBS-C tend to have higher levels of methane-producing microorganisms in their intestines compared to those with the diarrhea subtype. Methane slows intestinal transit, which partially explains why constipation dominates. Imbalances in gut bacteria can also increase intestinal permeability, worsen visceral hypersensitivity, and even contribute to anxiety and depression, which in turn feed back into gut symptoms.
Stress, particularly early-life stress, prior gut infections, and low-grade intestinal inflammation are all recognized risk factors. For many people, no single trigger explains the condition. It’s more like a feedback loop where gut sensitivity, altered motility, microbial shifts, and psychological stress all reinforce one another.
How Common IBS-C Is
IBS as a whole affects roughly 10 to 15% of the global population, but IBS-C is one of several subtypes. A large cross-sectional study across East Asia found IBS-C prevalence at about 2.1%, while the mixed subtype (alternating constipation and diarrhea) was more common at 6%. Prevalence varies by region and the diagnostic criteria used, but IBS-C consistently represents a meaningful share of IBS cases worldwide.
The Impact on Work and Daily Life
IBS-C affects more than physical comfort. Research consistently shows it reduces work productivity and quality of life. A U.S. study found that people with IBS-C had higher rates of presenteeism (being at work but underperforming due to symptoms), overall work impairment, and daily activity impairment compared to matched healthy controls. Anxiety about when symptoms might strike often compounds the problem, making it harder to commit to meetings, travel, or social plans.
The economic toll is measurable. In clinical trials, effective treatment of IBS-C reduced work productivity losses by the equivalent of 103 to 156 hours per year, translating to roughly $3,200 to $4,900 in avoided lost labor per person. IBS has even been associated with higher rates of unemployment in some countries. The condition’s unpredictability is a big part of why: it’s hard to explain to an employer that you can’t predict which mornings will be manageable.
How IBS-C Is Managed
Treatment typically starts with dietary and lifestyle changes. Soluble fiber is one of the most studied first-line approaches. Psyllium husk, the active ingredient in many over-the-counter fiber supplements, has been shown to improve symptoms at a dose of about 20 grams per day. It works by drawing water into stool, making it softer and easier to pass without the gas and bloating that insoluble fiber (like wheat bran) can worsen. Starting at a lower dose and building up gradually helps your gut adjust.
A low-FODMAP diet, which temporarily reduces certain fermentable carbohydrates, helps many people identify specific food triggers. Common culprits include garlic, onions, wheat, and certain fruits. The elimination phase is meant to be short-term, with foods gradually reintroduced to pinpoint which ones actually cause problems. Working with a dietitian makes the process more effective and reduces the risk of unnecessary dietary restriction.
Regular physical activity, stress management, and adequate hydration all support symptom control. For some people, these changes are enough. For others, they reduce symptom severity but don’t eliminate flare-ups.
Prescription Options
When lifestyle adjustments aren’t sufficient, several prescription medications are available specifically for IBS-C. These drugs work by increasing fluid secretion into the intestines, which softens stool and speeds transit. In clinical trials, the most effective of these had a response rate of 34% compared to 14% for placebo, meaning roughly one in five patients experienced meaningful improvement specifically because of the medication. Another option showed a 30% response rate versus 18% for placebo.
These aren’t dramatic cure rates, which reflects the complexity of IBS-C. Most gastroenterologists use a stepwise approach, trying the least invasive options first and layering treatments based on which symptoms respond. Some people benefit from medications that target the pain and sensitivity side of IBS-C rather than the constipation itself, including low-dose antidepressants that modulate how the gut and brain communicate. Gut-directed psychological therapies, particularly hypnotherapy focused on gut function, have also shown strong results in clinical trials.